y 27632 has been researched along with marimastat in 2 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (marimastat) | Trials (marimastat) | Recent Studies (post-2010) (marimastat) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 215 | 28 | 53 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrett, M; Burnitz, MC; Dipierro, C; Eto, M; Gibson, JJ; Myers, C; Phelps, C; Read, P; Somlyo, AP; Somlyo, AV | 1 |
Fallica, B; Maffei, JS; Srivastava, J; Zaman, MH | 1 |
2 other study(ies) available for y 27632 and marimastat
Article | Year |
---|---|
Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants.
Topics: Amides; Animals; Aorta, Thoracic; Cell Division; Cell Line; Drug Synergism; Enzyme Inhibitors; Humans; Hydroxamic Acids; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, SCID; Microscopy, Fluorescence; Myosin-Light-Chain Phosphatase; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; Phosphoprotein Phosphatases; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Pyridines; Rabbits; rho-Associated Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
Combinative in vitro studies and computational model to predict 3D cell migration response to drug insult.
Topics: Amides; Butadienes; Cell Line; Cell Movement; Computer Simulation; Enzyme Inhibitors; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Humans; Hydroxamic Acids; Immunoblotting; In Vitro Techniques; Matrix Metalloproteinases; Microscopy, Confocal; Models, Theoretical; Nitriles; Pyridines; RNA, Small Interfering; Signal Transduction | 2014 |